Tunable delocalization of unpaired electrons of nitroxide radicals for sickle-cell disease drug improvements.
Hydroxyurea is a drug recently approved to treat sickle cell diseases. Hydroxyurea benefits the patients by increasing the level of fetal hemoglobin via a nitroxide radical pathway. Here, we report an unpaired-electron-delocalization approach to tune the stability of nitroxide radicals. In this approach, the substitution by an unsaturated alkyl group containing conjugated C=C double bonds for the hydrogen on the nitrogen atom attached to the hydroxyl of hydroxyurea can significantly increase its ability to generate nitroxide radical. Furthermore, the increase can be remarkably enhanced by increasing the number of conjugated C=C double bonds. For a hydroxyurea derivative that contains two conjugated C=C double bonds, the reaction rate to generate its radical is 118 times faster than that of hydroxyurea, and for a hydroxyurea derivative containing 20 conjugated C=C double bonds, the reaction rate to form its radical is 238 times faster than that of hydroxyurea. For this reason, hydroxyurea derivatives with conjugated C=C double bonds may constitute new potential drugs for the treatment of sickle-cell diseases.
Hu
Yun Hang
YH
Ruckenstein
Eli
E
D000986:Antisickling Agents / Q000737:chemistry* / Q000494:pharmacology*; D004583:Electrons; D006801:Humans; D015394:Molecular Structure; D009589:Nitrogen Oxides / Q000737:chemistry* / Q000494:pharmacology*; D012805:Sickle Cell Trait / Q000188:drug therapy*; D013329:Structure-Activity Relationship
D000986:Antisickling Agents; D009589:Nitrogen Oxides; C039900:nitroxyl